Redmond Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Buy
2,025
+13
+0.6% +$4.45K 0.18% 135
2026
Q1
$708K Sell
2,012
-36
-2% -$12.8K 0.19% 136
2025
Q4
$670K Sell
2,048
-114
-5% -$36.2K 0.17% 138
2025
Q3
$610K Sell
2,162
-75
-3% -$21.8K 0.15% 149
2025
Q2
$625K Buy
2,237
+7
+0.3% +$1.98K 0.15% 145
2025
Q1
$695K Hold
2,230
0.18% 133
2024
Q4
$581K Buy
+2,230
New +$662K 0.15% 137

Other funds holding AMGN

Redmond Asset Management's AMGN Position: Q2 2026 in Review

Redmond Asset Management increased its Amgen (AMGN) stake by 0.65% in Q2 2026, buying an estimated $4.45K and bringing the position to 2,025 shares worth $733K. The position accounts for 0.18% of the portfolio, ranked #135.

Redmond Asset Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Redmond Asset Management held 2,025 shares of Amgen worth $733K as of Q2 2026.
  • Redmond Asset Management bought 13 Amgen shares in Q2 2026, an estimated $4.45K.
  • Amgen made up 0.18% of Redmond Asset Management's portfolio in Q2 2026, its #135 holding.
  • Redmond Asset Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Redmond Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.